Aristotle Atlantic Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.9M | Sell |
71,042
-2,566
| -3% | -$1.39M | 1.63% | 16 |
|
|
2025
Q4 | $42.7M | Sell |
73,608
-1,040
| -1% | -$588K | 1.95% | 13 |
|
|
2025
Q3 | $36.2M | Sell |
74,648
-1,727
| -2% | -$804K | 1.05% | 24 |
|
|
2025
Q2 | $31M | Buy |
76,375
+10,222
| +15% | +$4.27M | 0.94% | 30 |
|
|
2025
Q1 | $32.9M | Buy |
66,153
+2,298
| +4% | +$1.24M | 1.11% | 29 |
|
|
2024
Q4 | $33.2M | Sell |
63,855
-1,068
| -2% | -$587K | 1.04% | 23 |
|
|
2024
Q3 | $40.2M | Sell |
64,923
-23,021
| -26% | -$13.6M | 1.25% | 23 |
|
|
2024
Q2 | $48.6M | Sell |
87,944
-20,799
| -19% | -$11.9M | 1.58% | 18 |
|
|
2024
Q1 | $63.2M | Sell |
108,743
-21,933
| -17% | -$12.3M | 2.06% | 14 |
|
|
2023
Q4 | $69.4M | Buy |
130,676
+8,947
| +7% | +$4.33M | 2.44% | 8 |
|
|
2023
Q3 | $61.6M | Buy |
121,729
+7,990
| +7% | +$4.26M | 2.47% | 7 |
|
|
2023
Q2 | $59.3M | Buy |
113,739
+10,804
| +10% | +$5.83M | 2.23% | 8 |
|
|
2023
Q1 | $59.3M | Buy |
102,935
+5,515
| +6% | +$3.11M | 3.05% | 6 |
|
|
2022
Q4 | $53.6M | Buy |
97,420
+1,225
| +1% | +$649K | 3% | 7 |
|
|
2022
Q3 | $48.8M | Buy |
96,195
+36,389
| +61% | +$20.4M | 2.97% | 6 |
|
|
2022
Q2 | $32.5M | Buy |
59,806
+1,505
| +3% | +$828K | 2.5% | 8 |
|
|
2022
Q1 | $34.4M | Buy |
58,301
+863
| +2% | +$496K | 2.13% | 14 |
|
|
2021
Q4 | $38.3M | Buy |
57,438
+2,638
| +5% | +$1.65M | 2.22% | 13 |
|
|
2021
Q3 | $31.3M | Sell |
54,800
-4,520
| -8% | -$2.48M | 2.07% | 12 |
|
|
2021
Q2 | $29.9M | Buy |
59,320
+675
| +1% | +$318K | 1.97% | 15 |
|
|
2021
Q1 | $26.8M | Sell |
58,645
-1,695
| -3% | -$809K | 1.96% | 16 |
|
|
2020
Q4 | $28.1M | Sell |
60,340
-137
| -0.2% | -$64.2K | 2.17% | 15 |
|
|
2020
Q3 | $26.7M | Buy |
60,477
+827
| +1% | +$342K | 2.35% | 12 |
|
|
2020
Q2 | $21.6M | Buy |
59,650
+2,706
| +5% | +$907K | 2.08% | 19 |
|
|
2020
Q1 | $16.1M | Sell |
56,944
-1,598
| -3% | -$504K | 2.47% | 13 |
|
|
2019
Q4 | $19M | Buy |
58,542
+1,047
| +2% | +$317K | 2.43% | 14 |
|
|
2019
Q3 | $16.7M | Buy |
57,495
+876
| +2% | +$251K | 4.82% | 4 |
|
|
2019
Q2 | $16.6M | Buy |
56,619
+861
| +2% | +$237K | 4.83% | 5 |
|
|
2019
Q1 | $15.3M | Sell |
55,758
-136
| -0.2% | -$33.8K | 4.64% | 5 |
|
|
2018
Q4 | $12.5M | Buy |
55,894
+7,494
| +15% | +$1.76M | 4.41% | 4 |
|
|
2018
Q3 | $9.76M | Sell |
48,400
-4,860
| -9% | -$1.12M | 5.97% | 7 |
|
|
2018
Q2 | $11M | Buy |
53,260
+736
| +1% | +$156K | 3.83% | 8 |
|
|
2018
Q1 | $10.8M | Buy |
52,524
+518
| +1% | +$109K | 3.91% | 9 |
|
|
2017
Q4 | $9.88M | Buy |
+52,006
| New | +$9.96M | 3.54% | 9 |
|
Other funds holding TMO
VCM
Aristotle Atlantic Partners's TMO Position: Q1 2026 in Review
Aristotle Atlantic Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q1 2026, selling an estimated $1.39M and leaving 71,042 shares worth $34.9M. The position accounts for 1.63% of the portfolio, ranked #16.
Aristotle Atlantic Partners first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $69.4M in Q4 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Aristotle Atlantic Partners held 71,042 shares of Thermo Fisher Scientific worth $34.9M as of Q1 2026.
- Aristotle Atlantic Partners sold 2,566 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.39M.
- Thermo Fisher Scientific made up 1.63% of Aristotle Atlantic Partners's portfolio in Q1 2026, its #16 holding.
- Aristotle Atlantic Partners first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Aristotle Atlantic Partners's Thermo Fisher Scientific position peaked at $69.4M in Q4 2023.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Aristotle Atlantic Partners's 13F filing for Q1 2026, filed 15 May 2026.